Table 1:
Characteristics of CRIC participants without and with a successful aortic PWV measurement
| Characteristic | All Eligible | PWV Available | P Value | |
|---|---|---|---|---|
| n=3939 | No n=1144 | Yes n=2795 | ||
| Age (years) | 59.08 (11.08) | 56.99 (11.51) | 59.93 (10.78) | <.0001 |
| Gender (% Male) | 2161 (54.9%) | 585 (51.1%) | 1576 (56.4%) | 0.0026 |
| Race / ethnicity | . | |||
| Hispanic | 497 (12.6%) | 170 (14.9%) | 327 (11.7%) | <.0001 |
| Non-Hispanic Black | 1650 (41.9%) | 562 (49.1%) | 1088 (38.9%) | . |
| Non-Hispanic White | 1638 (41.6%) | 372 (32.5%) | 1266 (45.3%) | . |
| Other | 154 (3.91%) | 40 (3.5%) | 114 (4.1%) | . |
| Diabetes | 1996 (50.7%) | 673 (58.8%) | 1323 (47.3%) | <.0001 |
| eGFR (mL/min/1.73m2) (19) | 42.54 (17.54) | 38.10 (14.90) | 44.38 (18.21) | <.0001 |
| Weight (kg) | 91.35 (23.53) | 95.60 (28.31) | 89.60 (21.02) | <.0001 |
| Systolic BP (mmHg) | 128.75 (22.69) | 133.52 (24.14) | 126.79 (21.77) | <.0001 |
| Diastolic BP (mmHg) | 70.52 (12.98) | 72.20 (13.63) | 69.83 (12.64) | <.0001 |
| Seated Pulse measure (beats/min) | 68.04 (11.46) | 69.25 (11.79) | 67.54 (11.28) | <.0001 |
| Hemoglobin (g/dL) | 12.60 (1.80) | 12.21 (1.84) | 12.76 (1.76) | <.0001 |
| Serum Creatinine (mg/dL) | 1.98 (0.88) | 2.07 (0.75) | 1.94 (0.92) | <.0001 |
| Triglycerides | 156.28 (116.50) | 171.45 (131.71) | 148.88 (107.56) | <.0001 |
| Calcium (mg/dL) | 9.26 (0.53) | 9.12 (0.56) | 9.31 (0.50) | <.0001 |
| Phosphate (mg/dL) | 3.82 (0.72) | 3.91 (0.73) | 3.56 (0.64) | <.0001 |
| Total Parathyroid Hormone (pg/ml) | 84.13 (85.25) | 93.96 (86.40) | 68.15 (80.89) | <.0001 |
| 24H Urine Protein (g/24H) | 1.16 (2.45) | 1.82 (3.25) | 0.86 (1.90) | <.0001 |
| Hemoglobin A1C (%) | 6.91 (1.62) | 6.98 (1.75) | 6.86 (1.52) | 0.0746 |
| Uric Acid (mg/dL) | 7.60 (1.98) | 7.76 (1.97) | 7.17 (1.94) | <.0001 |
| % Participants on ACE-inhibitor or ARB | 2714 (69.4%) | 786 (69.3%) | 1928 (69.4%) | 0.9434 |
| % Participants on Calcium antagonist | 1621 (41.4%) | 521 (45.9%) | 1100 (39.6%) | 0.0003 |
| % Participants on Beta blockers | 2009 (51.4%) | 658 (58%) | 1351 (48.6%) | <.0001 |
| % Participants on Diuretics | 2341 (59.9%) | 791 (69.8%) | 1550 (55.8%) | <.0001 |
| # Anti-HT Drug Classes | 2.52 (1.28) | 2.76 (1.19) | 2.42 (1.30) | <.0001 |
| Age (years) | 59.08 (11.08) | 56.99 (11.51) | 59.93 (10.78) | <.0001 |
| Gender (% Male) | 2161 (54.9%) | 585 (51.1%) | 1576 (56.4%) | 0.0026 |